CME
Molecular-Driven Treatment Advances in HER2+ Metastatic Colorectal Cancer
Host: Tanios S. Bekaii-Saab, MD Guest: Joleen M. Hubbard, MD Are you familiar with the most recent clinical data surrounding the treatment of HER2-positive metastatic colorectal cancer? Listen in as Drs. Tanios Bekii-Saab and Joleen Hubbard